X. Carrero

发表

Phase II trial of pirfenidone in adults with neurofibromatosis type 1

B. O'neill, K. Ballman, N. Lindor, 2006, Neurology.

NCCTG N0574 (Alliance): A phase III randomized trial of whole brain radiation therapy (WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain metastases.

J. Buckner, A. Asher, C. Ménard, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Anorectal Function and Quality of Life in Patients With Early Stage Rectal Cancer Treated With Chemoradiation and Local Excision

Q. Shi, J. Garcia-Aguilar, L. Renfro, 2017, Diseases of the colon and rectum.

Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3)

P. Brown, C. Hadjipanayis, C. Jan, 2020 .

Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis: A Secondary Analysis of The N107C/CEC.3 (Alliance for Clinical Trials in Oncology/Canadian Cancer Trials Group) Randomized Clinical Trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2022, JAMA oncology.

Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group N0574 (Alliance) Randomized Controlled Trial.

J. Buckner, P. Brown, A. Asher, 2017, International journal of radiation oncology, biology, physics.

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Mark D Anderson, Jennie W. Taylor, Mark D. Anderson, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

ORGAN PRESERVATION FOR CLINICAL T2N0 DISTAL RECTAL CANCER USING NEOADJUVANT CHEMORADIOTHERAPY AND LOCAL EXCISION: RESULTS OF A MULTICENTER PHASE 2 STUDY

P. Cataldo, E. Chan, A. Pigazzi, 2015, The Lancet. Oncology.

A phase 1 and randomized, placebo‐controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872

J. Buckner, D. Tran, D. Schiff, 2019, Cancer.

Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial.

J. Buckner, P. Brown, C. Hadjipanayis, 2017, The Lancet. Oncology.

Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.

Volker W Stieber, Cynthia Ménard, Jan C Buckner, 2016, JAMA.

Optimizing whole brain radiotherapy dose and fractionation: Results from a prospective phase III trial (NCCTG N107C (Alliance)/CEC.3).

J. Buckner, P. Brown, C. Hadjipanayis, 2019, International journal of radiation oncology, biology, physics.

Final report from intergroup NCCTG 86-72-51 (Alliance): a phase 3 randomized clinical trial of high dose versus low dose radiation for adult low-grade glioma.

E. Shaw, B. O'neill, W. Curran, 2020, Neuro-oncology.

Perioperative Gemcitabine + Erlotinib Plus Pancreaticoduodenectomy for Resectable Pancreatic Adenocarcinoma: ACOSOG Z5041 (Alliance) Phase II Trial

D. Sahani, J. Meyerhardt, Douglas B. Evans, 2019, Annals of Surgical Oncology.

CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.

B. Scheithauer, J. O'fallon, B. O'neill, 2011, International journal of radiation oncology, biology, physics.

N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery (SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected Metastatic Brain Disease

J. Buckner, P. Brown, C. Hadjipanayis, 2016 .

Adult patients with supratentorial pilocytic astrocytoma: long-term follow-up of prospective multicenter clinical trial NCCTG-867251 (Alliance).

E. Shaw, B. O'neill, W. Curran, 2015, Neuro-oncology practice.

Optimizing Whole Brain Radiotherapy Dose and Fractionation: Results from a Prospective Phase III Trial (NCCTG N107C (Alliance)/CEC.3)

J. Buckner, P. Brown, E. Galanis, 2019, International Journal of Radiation Oncology*Biology*Physics.

BMET-05NCCTG N0574 (ALLIANCE): A PHASE III RANDOMIZED TRIAL OF WHOLE BRAIN RADIATION THERAPY (WBRT) IN ADDITION TO RADIOSURGERY (SRS) IN PATIENTS WITH 1 TO 3 BRAIN METASTASES

J. Buckner, P. Brown, A. Asher, 2015 .